Free Review Articles on Kidney (Chronic renal failure)                                 Metatextbook

Freie Reviews über Niere (Insuffizienz chronische)                                 Look here for Journal Homepages




  • Kidney (Chronic renal failure)
  • Creatinine
  • Aldosterone
  • Anemia (Renal)
  • RAAS (Renin angiotensin system)
  • Proteomics
  • Sarcopenia
  • Obesity
  • Uric acid (Hyperuricemia)
  • Vitamin D
  • Statin
  • Diuretic agents (BASKET)
  • Kidney (Glomerulus)
  • ZONAB
  • Homocysteine
  • Fibrosis
  • Receptor (PPAR)
  • Acidosis (metabolic)
  • Cardiorenal syndrome
  • RAAS (AngiotensinII)
  • Kidney (Pressure natriuresis)
  • Kidney (Fibrosis)
  • Kidney (Microcirculation)
  • Kidney (Medulla)
  • Redox (BASKET)
  • Nitric oxide NO
  • NADPH oxidase
  • Kidney (Mesangial cell)
  • Receptor (Mineralcorticoid)
  • Endothelin
  • Endothelial dysfunction
  • Nifedipine
  • Nitrosonifedipine
  • Receptor (Pro Renin)
  • HIF1alpha und HIF1 (BASKET)
  • Prolyl hydroxylases
  • Implanted cardioverter defibrillator
  • Cardiovascular risk
  • Arterial hypertension (BASKET)
  • Hepcidin
  • Cinacalcet
  • PTH (Hyperparathyreoidism secondary)
  • Nr.Year

    OPEN

    Titleusers

    say

    rate

    good

    rate

    bad

    no link

    Citation
    12002Chronic renal disease.



    +-nlBMJ 325(7355):85-90 (2002)
    22010Chronic kidney disease: whom to screen and how to treat, part 1: definition, epidemiology, and laboratory testing.



    +-nlSouth Med J 103(2):140-6 (2010)
    32008The ABCDEs of CKD: a simple approach to early detection and management.



    +-nlSouth Med J 101(10):1001-6 (2008)
    42004Proteinuria and microalbuminuria in adults: significance, evaluation, and treatment.



    +-nlSouth Med J 97(10):969-79 (2004)
    51994Pathophysiology of progressive renal failure.



    +-nlSouth Med J 87(10):1028-33 (1994)
    62009Discharging patients from the nephrology clinic to primary care--will they get appropriate monitoring of renal function?



    +-nlQJM 102(6):425-8 (2009)
    72008Role of chronic hypoxia and hypoxia inducible factor in kidney disease.



    +-nlChin Med J (Engl) 121(3):257-64 (2008)
    82003Progression of chronic renal failure.



    +-nlArch Intern Med 163(12):1417-29 (2003)
    91998Chronic renal insufficiency: a diagnostic and therapeutic approach.



    +-nlArch Intern Med 158(16):1743-52 (1998)
    102006Natural history of elevated creatinine levels.



    +-nlCan Fam Physician 52(10):1264-5 (2006)
    112001Identifying and slowing progressive chronic renal failure.



    +-nlCan Fam Physician 47(-):2512-8 (2001)
    122000End-stage renal disease. Timely, appropriate treatment is crucial.



    +-nlCan Fam Physician 46(-):511-2, 522-4 (2000)
    132008Chronic kidney disease and its complications.



    +-nlPrim Care 35(2):329-44, vii (2008)
    142001Cardiovascular complications of renal disease.



    +-nlHeart 86(4):459-66 (2001)
    152007Causes and consequences of chronic kidney disease: implications for managed health care.



    +-nlJ Manag Care Pharm 13(3 Suppl):S1-9 (2007)
    161980Nutritional assessment and treatment of chronic renal failure.



    +-nlAm J Clin Nutr 33(7):1586-97 (1980)
    171980Symposium on nutrition in renal disease. Proceedings of the Second International Congress on Nutrition in Renal Disease; June 13--15, 1979, Bologna, Italy.



    +-nlAm J Clin Nutr 33(7):1342-702 (1980)
    181997Abnormal lipid metabolism and renal disorders.



    +-nlTohoku J Exp Med 181(3):321-37 (1997)
    191992Preservation of renal function in chronic renal failure.



    +-nlTohoku J Exp Med 166(1):165-83 (1992)
    202009Early angiography in patients with chronic kidney disease: a collaborative systematic review.



    +-nlClin J Am Soc Nephrol 4(6):1032-43 (2009)
    212009Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis.



    +-nlClin J Am Soc Nephrol 4(3):542-51 (2009) Navaneethan SD
    222006Do we know the correct hemoglobin target for anemic patients with chronic kidney disease?



    +-nlClin J Am Soc Nephrol 1(4):678-84 (2006)
    232006Aldosterone antagonism in chronic kidney disease.



    +-nlClin J Am Soc Nephrol 1(4):668-77 (2006) Ponda MP
    242009Optimal preparation for ESRD.



    +-nlClin J Am Soc Nephrol 4 Suppl 1(-):S110-3 (2009)
    252008Nitric oxide deficiency in chronic kidney disease.



    +-nlAm J Physiol Renal Physiol 294(1):F1-9 (2008)
    261971Function of the chronically diseased kidney. The adaptive nephron.



    +-nlCirc Res 28(5):Suppl 2:1-13 (1971)
    272008Treating elderly people with diabetes and stages 3 and 4 chronic kidney disease.



    +-nlClin J Am Soc Nephrol 3(4):1185-94 (2008)
    282007The unique character of cardiovascular disease in chronic kidney disease and its implications for treatment with lipid-lowering drugs.



    +-nlClin J Am Soc Nephrol 2(4):766-85 (2007)
    292004Causes and consequences of increased sympathetic activity in renal disease.



    +-nlHypertension 43(4):699-706 (2004)
    302003Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.



    +-nlHypertension 42(5):1050-65 (2003)
    311993Essential hypertension: a renal disease? A review and update of the evidence.



    +-nlHypertension 21(3):380-90 (1993)
    321980Antihypertensive functions of the kidney: Arthur C. Corcoran memorial lecture.



    +-nlHypertension 2(4):444-64 (1980)
    332009Timing of onset of CKD-related metabolic complications.



    +-nlJ Am Soc Nephrol 20(1):164-71 (2009)
    342008Staging of chronic kidney disease: time for a course correction.



    +-nlJ Am Soc Nephrol 19(5):844-6 (2008)
    352007Frontiers in nephrology: early atherosclerosis--a view beyond the lumen.



    +-nlJ Am Soc Nephrol 18(11):2836-42 (2007)
    362007Frontiers in nephrology: viewing the kidney through the heart--endothelial dysfunction in chronic kidney disease.



    +-nlJ Am Soc Nephrol 18(11):2833-5 (2007)
    372006Chronic kidney disease and mortality risk: a systematic review.



    +-nlJ Am Soc Nephrol 17(7):2034-47 (2006)
    382004Sympathetic hyperactivity in chronic renal failure: a wake-up call.



    +-nlJ Am Soc Nephrol 15(3):524-37 (2004)
    391991Cardiovascular complications in renal failure.



    +-nlJ Am Soc Nephrol 2(6):1053-62 (1991)
    401991The natural history of myocardial disease in dialysis patients.



    +-nlJ Am Soc Nephrol 2(1):2-12 (1991)
    412001Coronary artery disease in uremia: Etiology, diagnosis, and therapy.



    +-nlKidney Int 60(6):2059-78 (2001)
    421995Treatment of children with chronic renal failure.



    +-nlKidney Int 47(3):951-61 (1995)
    432007Chronic kidney disease: effects on the cardiovascular system.



    +-nlCirculation 116(1):85-97 (2007)
    442008Diagnosis and management of chronic kidney disease.



    +-nlMayo Clin Proc 83(9):1064-9 (2008)
    452006Late referral of patients with chronic kidney disease: no time to waste.



    +-nlMayo Clin Proc 81(11):1487-94 (2006) Sprangers B
    462006Early referral for chronic kidney disease: good for those who need it, but who are they?



    +-nlMayo Clin Proc 81(11):1420-2 (2006)
    471998Uraemic cardiomyopathy.



    +-nlNephrol Dial Transplant 13 Suppl 4(-):39-43 (1998)
    482003National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification.



    +-nlPediatrics 111(6 Pt 1):1416-21 (2003)
    492008Guidelines for the management of chronic kidney disease.



    +-nlCMAJ 179(11):1154-62 (2008) Levin A
    502008Progress and promise in the management of chronic kidney disease.



    +-nlCMAJ 179(11):1107-8 (2008)
    512002Nephrology: 3. Safe drug prescribing for patients with renal insufficiency.



    +-nlCMAJ 166(4):473-7 (2002)
    521993Musculoskeletal manifestations of chronic renal insufficiency.



    +-nlRadiographics 13(2):357-79 (1993)
    532011The role of statins in chronic kidney disease.



    +-nlAm J Nephrol 34(3):195-202 (2011)
    542010Role of the intrarenal renin-angiotensin-aldosterone system in chronic kidney disease.



    +-nlAm J Nephrol 31(6):541-50 (2010)
    552010The use of targeted biomarkers for chronic kidney disease.



    +-nlAdv Chronic Kidney Dis 17(6):469-79 (2010)
    562010Mass spectrometry in chronic kidney disease research.



    +-nlAdv Chronic Kidney Dis 17(6):455-68 (2010)
    572008Progression from acute kidney injury to chronic kidney disease: a pediatric perspective.



    +-nlAdv Chronic Kidney Dis 15(3):278-83 (2008)
    582010Review of muscle wasting associated with chronic kidney disease.



    +-nlAm J Clin Nutr 91(4):1128S-1132S (2010)
    592005Survival advantages of obesity in dialysis patients.



    +-nlAm J Clin Nutr 81(3):543-54 (2005)
    602008The role of hyperuricemia and gout in kidney and cardiovascular disease.



    +-nlCleve Clin J Med 75 Suppl 5(-):S13-6 (2008)
    612009Vitamin D deficiency in children with chronic kidney disease: uncovering an epidemic.



    +-nlPediatrics 123(3):791-6 (2009)
    622007Effects of statins on renal function.



    +-nlMayo Clin Proc 82(11):1381-90 (2007)
    632002New insights into diuretic use in patients with chronic renal disease.



    +-nlJ Am Soc Nephrol 13(3):798-805 (2002)
    642002Role of the microvascular endothelium in progressive renal disease.



    +-nlJ Am Soc Nephrol 13(3):806-16 (2002)
    652003Prevention of the development and progression of renal disease.



    +-nlJ Am Soc Nephrol 14(7 Suppl 2):S144-7 (2003)
    662009The case for using albuminuria in staging chronic kidney disease.



    +-nlJ Am Soc Nephrol 20(3):465-8 (2009)
    672007Lipoprotein metabolism and lipid management in chronic kidney disease.



    +-nlJ Am Soc Nephrol 18(4):1246-61 (2007)
    682007More on renal disease progression: is interstitial inflammation truly protective?



    +-nlJ Am Soc Nephrol 18(6):1630-2 (2007) Perico N
    692009Sympathetic activation in chronic renal failure.



    +-nlJ Am Soc Nephrol 20(5):933-9 (2009)
    702009Metabolic acidosis and progression of chronic kidney disease.



    +-nlJ Am Soc Nephrol 20(9):1869-70 (2009) Frassetto LA
    712006Why is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering?



    +-nlNephrol Dial Transplant 21(5):1161-6 (2006)
    722006Are peroxisome proliferator-activated receptors new therapeutic targets in diabetic and non-diabetic nephropathies?



    +-nlNephrol Dial Transplant 21(10):2696-702 (2006)
    732006Hearing in renal failure.



    +-nlNephrol Dial Transplant 21(11):3023-30 (2006)
    742004Sympathetic hyperactivity in chronic kidney disease.



    +-nlNephrol Dial Transplant 19(6):1354-7 (2004)
    752009Progress with the European Society for Paediatric Nephrology (ESPN)/ERA-EDTA Registry for children with established renal failure (ERF).



    +-nlNephrol Dial Transplant 24(9):2615-7 (2009)
    762011Consequences and therapy of the metabolic acidosis of chronic kidney disease.



    +-nlPediatr Nephrol 26(1):19-28 (2011)
    772011Heat shock proteins in chronic kidney disease.



    +-nlPediatr Nephrol 26(7):1031-7 (2011)
    782008Therapeutic strategies to slow chronic kidney disease progression.



    +-nlPediatr Nephrol 23(5):705-16 (2008)
    792008Hypertension in children with chronic kidney disease: pathophysiology and management.



    +-nlPediatr Nephrol 23(3):363-71 (2008)
    802009End-stage renal disease: in vivo diffusion-tensor imaging of silent white matter damage.



    +-nlRadiology 252(2):518-25 (2009)
    812006Molecular mechanisms and therapeutic strategies of chronic renal injury: physiological role of angiotensin II-induced oxidative stress in renal medulla.



    +-nlJ Pharmacol Sci 100(1):2-8 (2006)
    822006Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effects of aldosterone blockade.



    +-nlJ Pharmacol Sci 100(1):9-16 (2006)
    832008Possible underlying mechanisms responsible for aldosterone and mineralocorticoid receptor-dependent renal injury.



    +-nlJ Pharmacol Sci 108(4):399-405 (2008)
    842009Drug discovery for overcoming chronic kidney disease (CKD): pharmacological effects of mineralocorticoid-receptor blockers.



    +-nlJ Pharmacol Sci 109(1):1-6 (2009)
    852009Drug discovery for overcoming chronic kidney disease (CKD): the endothelin ET B receptor/nitric oxide system functions as a protective factor in CKD.



    +-nlJ Pharmacol Sci 109(1):7-13 (2009)
    862009Drug discovery for overcoming chronic kidney disease (CKD): development of drugs on endothelial cell protection for overcoming CKD.



    +-nlJ Pharmacol Sci 109(1):14-9 (2009)
    872009Drug discovery for overcoming chronic kidney disease (CKD): new therapy for CKD by a (pro)renin-receptor-blocking decoy peptide.



    +-nlJ Pharmacol Sci 109(1):20-3 (2009)
    882009Drug discovery for overcoming chronic kidney disease (CKD): prolyl-hydroxylase inhibitors to activate hypoxia-inducible factor (HIF) as a novel therapeutic approach in CKD.



    +-nlJ Pharmacol Sci 109(1):24-31 (2009)
    892009Implantable cardioverter defibrillator therapy in chronic kidney disease: a meta-analysis.



    +-nlEuropace 11(11):1469-75 (2009)
    902011Estimated glomerular filtration rate and the risk of major vascular events and all-cause mortality: a meta-analysis.



    +-nlPLoS One 6(10):e25920 (2011)
    912003Nephrology: 4. Strategies for the care of adults with chronic kidney disease.



    +-nlCMAJ 168(12):1553-60 (2003)
    922010Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.



    +-nlHealth Technol Assess 14(21):1-184 (2010)
    932007Treatment of hypertension in patients with nondiabetic chronic kidney disease.



    +-nlCan J Cardiol 23(7):595-601 (2007)
    942009Hypertension in dialysis and kidney transplant patients.



    +-nlCan J Cardiol 25(5):309-14 (2009)
    952010Current status of the measurement of blood hepcidin levels in chronic kidney disease.



    +-nlClin J Am Soc Nephrol 5(9):1681-9 (2010)
    962010Survival benefits with vitamin D receptor activation: new insights since 2003.



    +-nlClin J Am Soc Nephrol 5(9):1704-9 (2010)
    972008Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: the ACHIEVE study results.



    +-nlClin J Am Soc Nephrol 3(6):1718-25 (2008)
    982008Improving global outcomes in mineral and bone disorders.



    +-nlClin J Am Soc Nephrol 3 Suppl 3(-):S127-30 (2008)
    992008Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?



    +-nlClin J Am Soc Nephrol 3(2):505-21 (2008)
    1002002Guidelines for initiation of renal replacement therapy: dialysis versus transplantation.



    +-nlSaudi J Kidney Dis Transpl 13(3):257-65 (2002)
    1012011The value of pre-dialysis care.



    +-nlSaudi J Kidney Dis Transpl 22(3):419-27 (2011)



    Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

    All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.